Accelerating the drug regulatory process through a federated cloud ecosystem

Key Points

• The drug regulatory process experiences increased efficiency with the implementation of a federated cloud ecosystem.
• Analysis shows that interoperability between systems led to a 30% reduction in approval times for new drugs.
• Observational analysis focused on how data sharing across platforms affects regulatory outcomes.
• Highlights the potential for significant improvements in drug approval timelines through advanced cloud technologies.